1. Home
  2. ENSC vs TAIT Comparison

ENSC vs TAIT Comparison

Compare ENSC & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • TAIT
  • Stock Information
  • Founded
  • ENSC 2003
  • TAIT 1989
  • Country
  • ENSC United States
  • TAIT United States
  • Employees
  • ENSC N/A
  • TAIT N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • ENSC Health Care
  • TAIT Technology
  • Exchange
  • ENSC Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • ENSC 6.4M
  • TAIT 6.1M
  • IPO Year
  • ENSC N/A
  • TAIT 1995
  • Fundamental
  • Price
  • ENSC $1.68
  • TAIT $1.17
  • Analyst Decision
  • ENSC
  • TAIT
  • Analyst Count
  • ENSC 0
  • TAIT 0
  • Target Price
  • ENSC N/A
  • TAIT N/A
  • AVG Volume (30 Days)
  • ENSC 79.2K
  • TAIT 290.6K
  • Earning Date
  • ENSC 11-14-2025
  • TAIT 11-14-2025
  • Dividend Yield
  • ENSC N/A
  • TAIT 11.86%
  • EPS Growth
  • ENSC N/A
  • TAIT N/A
  • EPS
  • ENSC N/A
  • TAIT N/A
  • Revenue
  • ENSC $4,487,973.00
  • TAIT $3,545,000.00
  • Revenue This Year
  • ENSC N/A
  • TAIT N/A
  • Revenue Next Year
  • ENSC N/A
  • TAIT N/A
  • P/E Ratio
  • ENSC N/A
  • TAIT N/A
  • Revenue Growth
  • ENSC 1.51
  • TAIT N/A
  • 52 Week Low
  • ENSC $1.53
  • TAIT $0.95
  • 52 Week High
  • ENSC $10.96
  • TAIT $5.10
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 30.16
  • TAIT 25.74
  • Support Level
  • ENSC $1.53
  • TAIT $0.95
  • Resistance Level
  • ENSC $2.17
  • TAIT $1.34
  • Average True Range (ATR)
  • ENSC 0.14
  • TAIT 0.12
  • MACD
  • ENSC -0.04
  • TAIT -0.10
  • Stochastic Oscillator
  • ENSC 24.81
  • TAIT 17.20

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: